The CorMatrix CanGaroo ECM Envelope is a pouch, which was developed to hold a CIED after implantation.

The envelope has been developed from a multi-laminate sheet of decellularized, non-crosslinked, lyophilized extracellular matrix derived from porcine small intestinal submucosa (SIS).

According to the company, ECM Envelope is available in four sizes, which will be suitable for different device types and sizes.

CorMatrix Cardiovascular sales and marketing executive vice-president John Davis said the CanGaroo has been designed, according to the needs described physicians to implant CIED’s in their daily practice.

"We are pleased that we can provide a device that our physician’s requested to address complications with CIED implantation," Davis added.

CorMatrix noted that CanGaroo ECM Envelope pre-clinical testing showed that it has been replaced with a vascularized tissue pouch at 90 day follow up, which isolated the CIED within the normal tissue.

The new vascularized tissue is said to allow for easy removal of the CIED in pre-clinical trials.

CorMatrix Cardiovascular CEO David Camp said: "The addition of the CanGaroo ECM Envelope to our portfolio of FDA-cleared devices is a major milestone for CorMatrix and strengthens our leadership in the field of ECM technologies."